Company Filing History:
6 out of 19 Years Active: 2018-2025
Title: The Innovative Journey of Justin W. Conway
Introduction
Justin W. Conway is an accomplished inventor based in Carignan, CA, known for his significant contributions to the formulation of oral films. With a total of seven patents to his name, his work reflects a commitment to advancing pharmaceutical delivery systems.
Latest Patents
One of his latest patents is titled "Lipophilic Active Oral Film Formulation and Method of Making the Same." This patent presents a method for creating oral films that incorporate lipophilic active ingredients, utilizing a carrier oil to disperse these ingredients uniformly within a polymer matrix. The technology enables the inclusion of up to 40% oil phase, providing a stable emulsion that maintains the desired film characteristics while facilitating easier administration and storage. Another notable patent is for an "Oral Film Formulation for Modulating Absorption Profile," which focuses on using high viscosity polymers to control the maximum concentration (Cmax) of active agents. This innovation allows for precise modulation of drug absorption, enhancing the therapeutic efficacy of oral film dosage forms.
Career Highlights
Justin Conway is currently associated with Intelgenx Corporation, a company dedicated to developing innovative drug delivery systems. His entrepreneurial spirit and dedication to research have led to the successful patenting of various formulations that improve patient compliance and product effectiveness in the pharmaceutical industry.
Collaborations
Throughout his career, Conway has collaborated with notable colleagues, including Rodolphe Obeid and Nadine Paiement. Their teamwork and collective expertise have contributed to the advancement of innovative solutions in drug delivery, further underscoring the significant impact of Conway’s work in the field.
Conclusion
Justin W. Conway exemplifies the role of an inventor committed to improving healthcare through innovation. His patents not only represent technological advancements but also aim to enhance patient experiences. As he continues to develop groundbreaking solutions within pharmaceutical formulations, Conway is set to leave a lasting mark on the industry.